TGF-β blood levels distinguish between influenza A (H1N1)pdm09 virus sepsis and sepsis due to other forms of community-acquired pneumonia

Viral Immunology

Volumn 28, Issue 5, 2015, Pages 248-254

  Rendón Ramirez, Erick J ^a   Ortiz Stern, Alejandro ^a   Martinez Mejia, Corazon ^a   Salinas Carmona, Mario C ^a   Rendon, Adrian ^a   Mata Tijerina, Viviana L ^b   Rosas Taraco, Adrian G ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER; CALCIUM; CHLORIDE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 6;

ADULT; APACHE; ARTICLE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LABORATORY TEST; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; BLOOD; COMMUNITY ACQUIRED INFECTION; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; MICROBIOLOGY; PNEUMONIA; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ADULT; BILIRUBIN; BIOMARKERS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKIN-8; MALE; PARTIAL THROMBOPLASTIN TIME; PNEUMONIA; PROTHROMBIN TIME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA;

EID: 84930853841     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0123     Document Type: Article

References (43)

1. Bautista E, Arcos M, Jimenez-Alvarez L, et al. Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection. Exp Mol Pathol 2013;94:486-492.
2. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-1719.
3. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009; 13:R201.
4. Bogdan C, and Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 1993;685:713-739.
5. Carlson CM, Turpin EA, Moser LA, et al. Transforming growth factor-beta: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathog 2010;6:e1001136.
6. Centers for Disease Control. CDC protocol of real time RTPCR for influenza A(H1N1). 2009; available at http://www.who.int/entity/csr/resources/publications/swineflu/CDCRealtimeRTPCR-SwineH1Assay-2009-20090430.pdf
7. Coupes BM, Williams S, Roberts IS, et al. Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients. Nephrol Dial Transplant 2001;16:361-367.
8. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005;6:135.
9. Cheng XW, Lu J, Wu CL, et al. Three fatal cases of pandemic 2009 influenza A virus infection in Shenzhen are associated with cytokine storm. Respir Physiol Neurobiol 2011;175:185-187.
10. Chernow B, Zaloga G, McFadden E, et al. Hypocalcemia in critically ill patients. Crit Care Med 1982;10:848-851.
11. Chiaretti A, Pulitano S, Barone G, et al. IL-1 beta and IL-6 upregulation in children with H1N1 influenza virus infection. Mediators Inflamm 2013;2013:495848.
12. Davey RT, Lynfield R, Dwyer DE, et al. The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One 2013;8:e57121.
13. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207.
14. de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
15. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-1887.
16. Fencl V, and Rossing TH. Acid-base disorders in critical care medicine. Annu Rev Med 1989;40:17-29.
17. Geyer AI, Kraus T, Roberts M, et al. Plasma level of interferon gamma induced protein 10 is a marker of sar-coidosis disease activity. Cytokine 2013;64:152-157.
18. Goto S, Aoike I, Shibasaki Y, et al. A successfully treated case of disseminated tuberculosis-associated hemophago-cytic syndrome and multiple organ dysfunction syndrome. Am J Kidney Dis 2001;38:E19.
19. Gursel G, and Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2006;73:503-508.
20. Kibe S, Adams K, and Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011;66:ii33-ii40.
21. Kinoshita Y, Furuta K, Ishimura N, et al. Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis. Digestion 2012;86:238-243.
22. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829.
23. Kohlmeier JE, and Woodland DL. Immunity to respiratory viruses. Annu Rev Immunol 2009;27:61-82.
24. Li C, Yang P, Sun Y, et al. IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. Cell Res 2012;22:528-538.
25. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-382.
26. Mares CA, Ojeda SS, Morris EG, et al. Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect Immun 2008;76:3001-3010.
27. Martinez-Ocana J, Olivo-Diaz A, Salazar-Dominguez T, et al. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09. J Clin Virol 2013;58:108-113.
28. Minne L, Abu-Hanna A, and de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care 2008;12:R161.
29. Mulrennan S, Tempone SS, Ling IT, et al. Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable. PLoS One 2010;5:e12849.
30. Murray CJ, Lopez AD, Chin B, et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006;368:2211-2218.
31. Napolitano LM. Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis 2010;51:S67-80.
32. Narvaez-Rivera RM, Rendon A, Salinas-Carmona MC, et al. Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis. BMC Infect Dis 2012;12:15.
33. Paquette SG, Banner D, Zhao Z, et al. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One 2012;7:e38214.
34. Parikh M, Dolson G, Ramanathan V, et al. Novel H1N1-associated rhabdomyolysis leading to acute renal failure. Clin Microbiol Infect 2010;16:330-332.
35. Periolo N, Avaro M, Czech A, et al. Pregnant women infected with pandemic influenza A(H1N1)pdm09 virus showed differential immune response correlated with disease severity. J Clin Virol 2015;64:52-58.
36. Riquelme R, Jimenez P, Videla AJ, et al. Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Int J Tuberc Lung Dis 2011;15:542-546.
37. Rodriguez-Ramirez HG, Salinas-Carmona MC, Barboza-Quintana O, et al. CD206 + cell number differentiates influenza A (H1N1)pdm09 from seasonal influenza A virus in fatal cases. Mediators Inflamm 2014;2014:921054.
38. Taubenberger JK, and Morens DM. The pathology of influenza virus infections. Annu Rev Pathol 2008;3:499-522.
39. Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:1179-1188.
40. Wakamoto H, Ohta M, and Nakano N. Hypercytokinemia in hemiconvulsions-hemiplegia syndrome associated with dual infection with varicella zoster and Epstein-Barr viruses. Neuropediatrics 2002;33:262-265.
41. Wen Y, Deng BC, Zhou Y, et al. Immunological features in patients with pneumonitis due to influenza A H1N1 infection. J Investig Allergol Clin Immunol 2011;21:44-50.
42. Yang SQ, Qu JX, Wang C, et al. Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period. Clin Respir J 2014;8:185-191.
43. Yu X, Zhang X, Zhao B, et al. Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLoS One 2011; 6:e28680.